We are live on ! Find out more
H

HoyleCohen Portfolio holdings

AUM $1.32B
1-Year Est. Return 27.05%
This Fund
S&P 500
This Quarter Est. Return
-4.92%
1 Year Est. Return
+27.05%
3 Year Est. Return
+46.07%
5 Year Est. Return
+145.61%
10 Year Est. Return
–
AUM
$913M
AUM Growth
-$47M
Cap. Flow
+$6.88M
Cap. Flow %
0.75%
Top 10 Hldgs %
33.21%
Holding
266
New
6
Increased
96
Reduced
105
Closed
9

Top Buys

Rank Stock Value
1
VT icon
Vanguard Total World Stock ETF
VT
+$3.46M
2
VUG icon
Vanguard Growth ETF
VUG
+$2.99M
3
VB icon
Vanguard Small-Cap ETF
VB
+$2.79M
4
VTV icon
Vanguard Value ETF
VTV
+$2.29M
5
VTI icon
Vanguard Total Stock Market ETF
VTI
+$1.78M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$1.82M
2
SCHA icon
Schwab U.S Small- Cap ETF
SCHA
+$1.53M
3
WTRG icon
Essential Utilities
WTRG
+$897K
4
IJS icon
iShares S&P Small-Cap 600 Value ETF
IJS
+$840K
5
MSFT icon
Microsoft
MSFT
+$737K

Sector Composition

Rank Sector Weight
1 Technology 22.45%
2 Financials 11.43%
3 Healthcare 9.8%
4 Consumer Discretionary 7.13%
5 Communication Services 6.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NAC icon
251
Nuveen California Quality Municipal Income Fund
NAC
$1.83B
$129K 0.01%
11,731
– –
AKTS
252
DELISTED
Akoustis Technologies Inc
AKTS
$110K 0.01%
36,902
– –
VIRX
253
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$60K 0.01%
14,000
– –
PSNL icon
254
Personalis
PSNL
$1.26B
$46K 0.01%
15,373
– –
SMMT icon
255
Summit Therapeutics
SMMT
$10.9B
$36K ﹤0.01%
30,432
– –
TCON
256
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$22K ﹤0.01%
650
– –
AMRN
257
Amarin Corp
AMRN
$284M
– –
-500
Closed -$15K
DIA icon
258
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.8B
– –
-683
Closed -$210K
GSK icon
259
GSK
GSK
$103B
– –
-4,853
Closed -$264K
LITE icon
260
Lumentum
LITE
$59.4B
– –
-2,874
Closed -$228K
MA icon
261
Mastercard
MA
$477B
– –
-684
Closed -$216K
MRNA icon
262
Moderna
MRNA
$21.5B
– –
-1,474
Closed -$211K
UGI icon
263
UGI
UGI
$8B
– –
-5,395
Closed -$208K
WTRG icon
264
Essential Utilities
WTRG
$11.2B
– –
-19,560
Closed -$897K
HYT.RT
265
DELISTED
BlackRock Corporate High Yield Fund, Inc. Rights (expiring October 13, 2022)
HYT.RT
$0 ﹤0.01%
+33,556
New +$191
AMPE
266
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
– –
-33
Closed -$2K
7 8 9 10
11

Similar funds

PRIG
Payden & Rygel Investment Group Los Angeles, California $1.24B AUM
HIG
Herr Investment Group Austin, Texas $1.5B AUM 29.27% 1-Year Est. Return
PO
Private Ocean San Rafael, California $1.13B AUM 11.01% 1-Year Est. Return
BPCA
Bank Pictet & Cie (Asia) Singapore $1.57B AUM 25.56% 1-Year Est. Return
GP
Girard Partners King Of Prussia, Pennsylvania $1.06B AUM 17.26% 1-Year Est. Return
AT
Arvest Trust Bartlesville, Oklahoma $1.68B AUM 14.24% 1-Year Est. Return
KI
Koch Industries Wichita, Kansas $853M AUM 37.49% 1-Year Est. Return
CDH
Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return

HoyleCohen's Q3 2022 Portfolio in Review

As of Q3 2022, HoyleCohen held 266 positions worth $913M, down 4.9% from $960M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

HoyleCohen's Q3 2022 filing shows 6 new, 96 increased, 105 reduced and 9 closed positions. Its largest new stake was Capital Group Global Growth Equity ETF: 11,936 shares worth $223K. The largest sale was Gilead Sciences, an estimated $1.82M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.

  • HoyleCohen's largest Q3 2022 buy was Capital Group Global Growth Equity ETF: 11,936 shares worth $223K.
  • HoyleCohen added most to Vanguard Total World Stock ETF in Q3 2022, an estimated $3.46M increase.
  • HoyleCohen's biggest Q3 2022 reduction was Gilead Sciences, cutting an estimated $1.82M.
  • HoyleCohen fully exited Essential Utilities in Q3 2022, selling an estimated $897K.
  • HoyleCohen's ten largest holdings make up 33% of its $913M portfolio in Q3 2022.
  • HoyleCohen opened 6 new positions and closed 9 in Q3 2022.
  • HoyleCohen's portfolio value fell 4.9% quarter-over-quarter to $913M.

Based on HoyleCohen's 13F filing for Q3 2022, filed 2 Nov 2022.